Predominant Factors Affecting Sexual Dysfunction on Patients with Continuous Ambulatory Peritoneal Dialysis
DOI:
https://doi.org/10.3889/oamjms.2021.6090Keywords:
Sexual dysfunction, Peritoneal dialysis, Chronic kidney diseaseAbstract
BACKGROUND: Sexual dysfunction is a complication of terminal kidney failure. The problem of fulfilling sexual needs of men undergoing Continuous Ambulatory Peritoneal Dialysis (CAPD) is influenced by many factors.
AIM: This study aims to find out the most dominant factor affecting the sexual dysfunction of men who undergo CAPD.
METHODS: The design of this study was cross-sectional analysis with a sample of 70 men CAPD patients using a purposive sampling technique from February to May 2020. Data collection was carried out offline and online by filling in the questionnaire sheets for respondent characteristics, International Index of Erectile Function, and looking at laboratory result.
RESULTS: The results showed there was a correlation between age (p=0.0024), plasma urea (p=0.018), and albumin (p=0.001) with sexual dysfunction in male patients using CAPD. There was no significant correlation between length of time undergoing CAPD (p=0.678), fasting glucose (0.051), triglycerides (p=0.536), and cholesterol (p=0.183) with sexual dysfunction in male patients who undergo CAPD. The most dominant factor affecting is albumin, where patients who have albumin levels < 3.5 g/dL are at risk of experiencing sexual dysfunction 9.3 times greater than patients with albumin levels 3.5-5 g/dL after being controlled by age variables.
CONCLUSION: The recommendation of this study is protein intake of 1.2-1.5 g/kg body weight with at least 60% of protein with high biological value and evaluation of the ability of care and replacement of CAPD at home.
Downloads
Metrics
Plum Analytics Artifact Widget Block
References
Kei LW. Kidney research and clinical practice metabolic syndrome and obesity in peritoneal dialysis. Kidney Res Clin Pract. 2016;35(1):10-4. https://doi.org/10.1016/j.krcp.2015.12.007 PMid:27069852 DOI: https://doi.org/10.1016/j.krcp.2015.12.007
Kirsten J. Sexual dysfunction in chronic kidney disease. Chronic Renal Dis. 2020;27(6):593-608. https://doi.org/10.1016/b978-0-12-815876-0.00037-1 DOI: https://doi.org/10.1016/B978-0-12-815876-0.00037-1
Rosas S, Joffe M, Franklin E, Strom BL, Kotzker W, Brensinger C, et al. Prevalence and determinants of erectile dysfunction in hemodialysis patients. Kidney Int. 2001;59(6):2259-66. https://doi.org/10.1046/j.1523-1755.2001.0590062259.x PMid:11380829 DOI: https://doi.org/10.1046/j.1523-1755.2001.00742.x
Indonesian Renal Registry. 11th Report of Indonesian Renal Registry. Indonesian: Indonesian Renal Registry; 2018.
Finkelstein F, Shirani S, Wuerth D, Finkelstein SH. Therapy insight: Sexual dysfunction in patients with chronic kidney disease. Nat Clin Pract Nephrol. 2007;3:200-7. https://doi.org/10.1038/ncpneph0438 PMid:17389889 DOI: https://doi.org/10.1038/ncpneph0438
Yudhistra PK, Farizal RM, Mahendrata RA. Validity and reliability of the Indonesian version of the international index of erectile function. J Clin Urol. 2020;1-5. https://doi.org/10.1177/2051415820927819 DOI: https://doi.org/10.1177/2051415820927819
Ploumis SP, Dimitrios GO. Diabetic patients on peritoneal dialysis. Wiley Online Lib. 2010;23:191-7. https://doi.org/10.1111/j.1525-139x.2010.00707.x DOI: https://doi.org/10.1111/j.1525-139X.2010.00707.x
Antonucci M, Palermo G, Salvatore MR, Bientinesi R, Presicce F, Foschi N, et al. Male sexual dysfunction in patients with chronic end-stage renal insufficiency and in renal transplant recipients. Arch Ital Urol Androl. 2015;87(4):299-305. https://doi.org/10.4081/aiua.2015.4.299 PMid:26766802 DOI: https://doi.org/10.4081/aiua.2015.4.299
Ferrini MG, Cadavid-Gonzalez NF, Rajfer J. Aging related erectile dysfunction-potential mechanism to halt or delay its onset. Transl Androl Urol. 2017;6:20-7. https://doi.org/10.21037/tau.2016.11.18 PMid:28217447 DOI: https://doi.org/10.21037/tau.2016.11.18
Mesquita JF, Ramos TF, Mesquita FP, Netto JM, Bastos MG, de Figueriedo AA. Prevalence of erectile dysfunction in chronic renal disease patients on conservative treatment. Clinics (Sao Paulo). 2012;67(2):181-3. https://doi.org/10.6061/clinics/2012(02)15 DOI: https://doi.org/10.6061/clinics/2012(02)15
Papadopoulou E, Varouktsi A, Lazaridis A, Boutari C, Doumas M, Papadopoulou E, et al. Erectile dysfunction in chronic kidney disease: From pathophysiology to management. World J Nephrol. 2015;4(3):379-87. https://doi.org/10.5527/wjn.v4.i3.379 PMid:26167462 DOI: https://doi.org/10.5527/wjn.v4.i3.379
Musch W, Verfaille L, Decaux G. Age related increase in plasma urea and decrease in fractional urea excretion: Clinical application in the syndrome of inappropriate secretion of antidiuretic hormone. Clin J Am Soc Nephrol. 2006;1(5):909-14. https://doi.org/10.2215/cjn.00320106 PMid:17699306 DOI: https://doi.org/10.2215/CJN.00320106
Yumi K, Tsutomu I, Hiromichi S. Role of nurses in a continuous ambulatory peritoneal diagnosis outpatient clinic. Karger. 2012;177:64-70. https://doi.org/10.1159/000336937 PMid:22613916 DOI: https://doi.org/10.1159/000336937
Kadiroglu AK, Ustundag S, Kayabashi H, Yilmaz Z, Yildrim Y, Sen S, et al. A comparative study of the effect of icodextrin based peritoneal dialysis and hemodialysis on lipid metabolism. Indian J Nephrol. 2013;23:358-61. https://doi.org/10.4103/0971-4065.116324 PMid:24049273 DOI: https://doi.org/10.4103/0971-4065.116324
John EH, Arthur CG. Guyton and Hall Textbook of Medical Physiology. Philadelphia, PA: Saunders Elsevier; 2011. p. 961-9.
Steven H. Hypoalbuminemia in peritoneal dialysis patients. Adv Perit Dial. 2013;29:55-60. PMid:24344493
Mehrotra R. Nutrional issues in peritoneal dialysis patients: How do they differ from that of patients undergoing hemodialysis? J Ren Nutr. 2013;23(3):237-40. https://doi.org/10.1053/j.jrn.2013.01.031 PMid:23611553 DOI: https://doi.org/10.1053/j.jrn.2013.01.031
Alves CF, Sun J, Qureshi AR, Dai L, Snaedal S, Barany P, et al. The higher mortality associated with low serum albumin is dependent on systemic inflammation in end-stage kidney disease. PLoS One. 2018;13:e0190410. https://doi.org/10.1371/journal.pone.0190410 PMid:29298330 DOI: https://doi.org/10.1371/journal.pone.0190410
Bonan NB, Schepers E, Pecoits-Filho R, Dhondt A, Pletinck A, De Somer F, et al. Contribution of the uremic milieu to an increased pro-inflammatory monocytic phenotype in chronic kidney disease. Sci Rep. 2019;9:1-11. https://doi.org/10.1038/s41598-019-46724-5-5 DOI: https://doi.org/10.1038/s41598-019-46724-5
Czub MP, Venkataramany BS, Majorek KA, Handing KB, Porebski PJ, Beeram SR, et al. Testosterone meets albumin-the molecular mechanism of sex hormone transport by serum albumins. Chem Sci. 2019;10:1607-18. https://doi.org/10.1039/c8sc04397c DOI: https://doi.org/10.1039/C8SC04397C
Downloads
Published
How to Cite
Issue
Section
Categories
License
Copyright (c) 2020 Yuswinda Kusumawardhani, Krisna Yetti, I Made Kariasa (Author)

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
http://creativecommons.org/licenses/by-nc/4.0